Intermittent Fasting Alleviates Diabetes-Associated Cognitive Impairment Through FGF21-Mediated Lipid Remodeling and Mitochondrial Redox Regulation
Antioxidants · 28.10.2026 · 15 (11) · 1397
DOI: 10.3390/antiox15111397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 28.10.2026. Verfasst von Fen Xiong und 9 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation, the Summit Advancement Disciplines of Zhejiang Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Cognitive impairment is a clinically relevant neurological complication of diabetes, yet its metabolic mechanisms remain incompletely understood. This study aimed to determine whether fibroblast growth factor 21 (FGF21), a fasting-responsive metabolic hormone, mediates the neuroprotective effects of intermittent fasting (IF) in diabetes-associated cognitive impairment, and to explore the underlying mechanisms.
Methods
Streptozotocin (STZ)-induced type 1 diabetes-associated cognitive impairment (T1DCI) mice were used together with FGF21 genetic deletion and exogenous FGF21 supplementation. Cognitive function, neuronal injury, hippocampal lipid metabolism, mitochondrial function, protein acetylation, and SIRT3-associated deacetylation were evaluated.
Results
IF significantly increased FGF21 levels in serum and hippocampus and improved cognitive deficits, whereas these effects were attenuated in FGF21-deficient mice. FGF21 supplementation improved cognitive performance and attenuated neuronal damage, accompanied by MAPK-related signaling changes. Lipidomic analysis revealed decreased phosphatidylcholine and triacylglycerols in the hippocampus of T1DCI mice, which were partially restored by FGF21. Consistently, FGF21 increased the expression of LPIN3, DGAT2, and CHPT1, key enzymes involved in PC and TAG biosynthesis. FGF21 also improved mitochondrial function and was associated with reduced protein acetylation, while SIRT3 inhibition attenuated these effects.
Conclusions
These findings suggest that FGF21 contributes to the neuroprotective effects of IF in diabetes-associated cognitive impairment, potentially through coordinated regulation of lipid metabolism and mitochondrial function.
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation
- the Summit Advancement Disciplines of Zhejiang Province
Zitieren
APA
Xiong, F., Jiang, K., Yan, X., Tang, T., Wang, X., Peng, Y., Guan, R., Zhang, X., Li, C., & Gao, H. (2026). Intermittent Fasting Alleviates Diabetes-Associated Cognitive Impairment Through FGF21-Mediated Lipid Remodeling and Mitochondrial Redox Regulation. Antioxidants, 15(11), 1397. https://doi.org/10.3390/antiox15111397
Vancouver
Xiong F, Jiang K, Yan X, Tang T, Wang X, Peng Y, et al. Intermittent Fasting Alleviates Diabetes-Associated Cognitive Impairment Through FGF21-Mediated Lipid Remodeling and Mitochondrial Redox Regulation. Antioxidants. 2026;15(11):1397. doi:10.3390/antiox15111397
BibTeX
@article{Xiong2026,
author = {Xiong, Fen and Jiang, Kaiyuan and Yan, Xiaoqing and Tang, Tian and Wang, Xinran and Peng, Yiwen and Guan, Ruoxin and Zhang, Xi and Li, Chen and Gao, Hongchang},
title = {Intermittent Fasting Alleviates Diabetes-Associated Cognitive Impairment Through FGF21-Mediated Lipid Remodeling and Mitochondrial Redox Regulation},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1397},
doi = {10.3390/antiox15111397}
}
EUVIMED